A 72-year-old woman with a history of atrial fibrillation is on digoxin therapy. She presents with nausea, visual disturbances (yellow-green halos), and a heart rate of 35 bpm. An ECG shows a prolonged PR interval and a characteristic 'sagging' ST segment. Which phase of the cardiac action potential is most directly affected by digoxin toxicity in the AV node?